首页> 外文期刊>Acta tropica: Journal of Biomedical Sciences >IgG reactivity with 40-35 kDa soluble and membrane antigen of Strongyloides venezuelensis in immunocompromised patients
【24h】

IgG reactivity with 40-35 kDa soluble and membrane antigen of Strongyloides venezuelensis in immunocompromised patients

机译:IgG反应性与40-35kDa可溶性和抗酮胰岛素抗原在免疫锥体患者中的抗肽和膜抗原

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Immunocompromised patients constitute a risk group for the development of severe clinical forms of human strongyloidiasis. The diagnosis of this infection is primarily performed by parasitological techniques, but with low sensitivity. Serological techniques appear as an alternative, especially with heterologous antigens use. The aim of this study was to perform the Western blot technique by using S. venezuelensis infective third stage larva (iL3) soluble (TS) and membrane (TM) saline antigens to reveal immunoreactive bands in immunocompromised patients with strongyloidiasis. Serum samples from 117 parasitologically well-characterized patients were divided into four groups: S. stercoralis positive and immunocompetent (S + IC); S. stercoralis positive and immunocompromised (S + IP); negative and immunocompetent (S-IC); negative and immunocompromised (S-IP). A 40-35 kDa band was recognized by 100% of patients in the S + IC group in both antigenic fractions, and by 62.5% and 50% in the S + IP group using the TS and TM fractions, respectively. A 29 kDa band was recognized by 86.3% and 72.7% (for TS and TM, respectively) of patients in the S + IC group, and only by 12.5% of patients in the S + IP group on the TM antigen. Regardless of the patients' immunological condition, the 40-35 kDa band from S. venezuelensis was detected more frequently and can be used as an important marker to the immunodiagnosis of human strongyloidiasis.
机译:免疫血肿患者构成了人类抗临床形式的严重临床形式的风险组。这种感染的诊断主要由寄生技术进行,但敏感性低。血清学技术表现为替代方案,特别是具有异源抗原的使用。本研究的目的是通过使用S. venezuelensis感染性第三阶段幼虫(IL3)可溶性(TM)和膜(TM)盐抗原来进行Western印迹技术,以揭示免疫抑制患者的抗抗免疫引发患者的免疫反应带。血清样品从117级寄生学上表征患者分为四组:S.Stercoralis阳性和免疫活性剂(S + IC); S. stercoralis积极和免疫功能(S + IP);阴性和免疫功能性(S-IC);消极和免疫功能(S-IP)。在抗原馏分的抗原级分中的S + IC组中的100%患者可获得40-35 kda乐队,分别使用TS和TM级分在S + IP组中得到62.5%和50%。 S + IC组患者的86.3%和72.7%(分别为TS和TM,分别为72.7%(TS和TM,分别均为TM抗原上的S + IP组患者的患者。无论患者的免疫病症如何,更频繁地检测到来自S.委内瑞的40-35 kDa带。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号